about
Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database.Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Switching statins in Norway after new reimbursement policy: a nationwide prescription study.Grandmother's smoking when pregnant with the mother and asthma in the grandchild: the Norwegian Mother and Child Cohort StudyUse of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.ADHD treatment and diagnosis in relation to children's birth month: Nationwide cohort study from Norway.Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study.Pre-eclampsia and childhood asthma.Maternal plasma total neopterin and kynurenine/tryptophan levels during pregnancy in relation to asthma development in the offspring.Prenatal and infant paracetamol exposure and development of asthma: the Norwegian Mother and Child Cohort Study.Maternal Folate Intake during Pregnancy and Childhood Asthma in a Population-based Cohort.The duration and course of opioid therapy in patients with chronic non-malignant pain.Prescription patterns of inhaled corticosteroids for preschool children--A Norwegian register study.Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway.Co-morbidity in persistent opioid users with chronic non-malignant pain in Norway.Comorbidities in an asthma population 8-29 years old: a study from the Norwegian Prescription Database.Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.Association of Maternal Psychosocial Stress With Increased Risk of Asthma Development in Offspring.Increased prescription rates of anxiolytics and hypnotics to survivors of cancer in childhood, adolescence, and young adulthood-A population-based study.Prescribing of asthma drugs for children 2004-2015.Trends in Use of Paracetamol in the Nordic Countries.Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databasesMaternal history of miscarriages and measures of fertility in relation to childhood asthmaVitamin A and D intake in pregnancy, infant supplementation, and asthma development: the Norwegian Mother and Child CohortLower Cancer Incidence—Warfarin Effect or Immortal Time Bias?A prospective study of asthma and subsequent use of hypnotics in young adultsNonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization StudyIs the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data SourcesAirway symptoms and atopy in young children prescribed asthma medications: A large-scale cohort studyAntidiabetic medication use during pregnancy: an international utilization studyAdjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomesAssociation Between Antibiotics in the First Year of Life and Celiac DiseaseComparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological studyPrevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia
P50
Q31146596-A521D228-9CD6-46CA-9006-47DA09257A19Q35038355-EE8C201D-6BCF-4400-9D30-FB118B33C82DQ35072050-44A831A7-F3B3-4288-9900-C879390405FAQ35907700-E1837A51-E805-4D3D-BF2D-6DF32EC98DECQ35937961-D8BF3973-C05F-49DC-A193-BDBFD489E29CQ36102629-ABE16F80-8119-40DA-85FB-4B8DF5F4F8CCQ37279693-3A0694EE-83DF-4DCA-A371-BAAB05DA7774Q37416392-03C2EFFA-A0D0-44F8-B56D-DBF70D4C6B43Q38749608-B9648CCC-1CF3-484B-8103-7301255AD063Q38797673-20991DE1-1AB6-4156-9360-2D9E0FE0A0E9Q39189605-01DD8DCA-CDEF-489E-A33A-AD5F73017A72Q39204967-E9DD00B1-FE1B-45DE-BB71-D7F4AAEA512EQ39739122-4692D0AC-AE93-4857-96D6-A7750E0A8A90Q40118901-12919CFE-BCEE-48F5-AEF7-04F91F412B6EQ40624603-0D22ADE7-CA0F-4A0F-BF82-D8FD45222589Q40660568-8032A4B9-F7B9-4A4B-8CC9-789536BE9394Q40798361-A06D6C94-AC7E-40C3-A223-7060AB9A672EQ44341357-DC15AEF6-EB24-4A35-8409-5904F5514A2FQ44343002-E9965F87-790B-4851-92D5-895D3AE349C0Q44395116-E63FCBF9-64B1-4964-89B2-198350AAFFF7Q47313347-6C365378-498C-4B06-8244-01469604D1F0Q47574471-43C162B5-5D7F-4C51-AB63-01F0B61C20B9Q47587521-7EF72F17-6161-4158-B45C-D2093E82C5C1Q49821144-BB59D708-2C6D-44CF-A276-95A42EEDFD4CQ51764124-31F39088-B551-41D7-8CB2-E187AD589262Q57129353-97112325-C467-45E0-A158-F8D661C0B2AAQ61849118-557875F6-72B2-41E6-80BF-8260DAC93868Q61856918-75D4CC87-72B6-46D1-B2E6-768EDA8FBF0BQ61856919-C910E794-3B9A-4B4D-ADBE-55F84798FD5EQ61856920-296DF74A-2B4E-436E-82BF-93A7B6F141ACQ64118616-98F56708-C15A-4C06-A4A3-E89F1C992793Q89907103-855A4EC5-1408-403D-86E2-4964106134AEQ91627527-2781444B-A91A-41EF-8C5E-73C0A89C3396Q91672989-9CE55AF9-D20C-4DC9-A10D-2F925A01EFD7Q92091724-820464B6-F9A4-4987-930A-267C538E6A65Q92142741-BA6A52C4-F9D3-4E4B-9747-AB16943F34C5Q92867382-EC3446AB-49A9-4813-923D-E902EF59B4ADQ96124545-80BAEA2F-909E-4EE7-937E-E99CF621FFE1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Øystein Karlstad
@ast
Øystein Karlstad
@en
Øystein Karlstad
@es
Øystein Karlstad
@nl
type
label
Øystein Karlstad
@ast
Øystein Karlstad
@en
Øystein Karlstad
@es
Øystein Karlstad
@nl
prefLabel
Øystein Karlstad
@ast
Øystein Karlstad
@en
Øystein Karlstad
@es
Øystein Karlstad
@nl
P106
P1153
21739510300
P21
P31
P496
0000-0003-1204-787X